Chief Financial Officer
Eric has over thirty years of industry experience and a proven track record of leadership in building successful, high-growth companies in partnership with private equity firms, which have resulted in significant value creation for shareholders. He most recently served as CFO for TriPharm Services, which was acquired by Alcami in January 2020. Before TriPharm, he was CFO of Avista Pharma Solutions, where he played a key role in the expansion and sale of the company. Before Avista, he was CFO of Mayne Pharma US, a publicly-traded company operating in the generic, brand, and CDMO pharmaceutical industries, and, at private-equity backed AAIpharma Services, where he supported a successful expansion strategy. Other prior pharmaceutical leadership roles include CFO of Patheon Inc, a publicly-traded and private equity-backed CDMO at the time, and various senior finance roles with Novartis, including CFO of Sandoz Pharmaceuticals, Vice President and Controller of Novartis Pharmaceuticals and Vice President Finance of Novartis Pharmaceuticals.